- Home
- TOMZ vs CING Comparison
TOMZ vs CING Comparison
Compare TOMZ & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- CING
- Stock Information
- Founded
- TOMZ 1979
- CING 2012
- Country
- TOMZ United States
- CING United States
- Employees
- TOMZ N/A
- CING N/A
- Industry
- TOMZ Diversified Commercial Services
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- TOMZ Finance
- CING Health Care
- Exchange
- TOMZ Nasdaq
- CING Nasdaq
- Market Cap
- TOMZ 20.3M
- CING 23.0M
- IPO Year
- TOMZ N/A
- CING 2021
- Fundamental
- Price
- TOMZ $0.90
- CING $3.70
- Analyst Decision
- TOMZ Strong Buy
- CING Strong Buy
- Analyst Count
- TOMZ 1
- CING 4
- Target Price
- TOMZ $3.50
- CING $33.00
- AVG Volume (30 Days)
- TOMZ 47.6K
- CING 202.4K
- Earning Date
- TOMZ 11-07-2025
- CING 11-06-2025
- Dividend Yield
- TOMZ N/A
- CING N/A
- EPS Growth
- TOMZ N/A
- CING N/A
- EPS
- TOMZ N/A
- CING N/A
- Revenue
- TOMZ $6,219,036.00
- CING N/A
- Revenue This Year
- TOMZ $18.31
- CING N/A
- Revenue Next Year
- TOMZ $103.30
- CING N/A
- P/E Ratio
- TOMZ N/A
- CING N/A
- Revenue Growth
- TOMZ N/A
- CING N/A
- 52 Week Low
- TOMZ $0.63
- CING $3.02
- 52 Week High
- TOMZ $1.50
- CING $6.01
- Technical
- Relative Strength Index (RSI)
- TOMZ 40.73
- CING 41.11
- Support Level
- TOMZ $0.93
- CING $3.73
- Resistance Level
- TOMZ $0.98
- CING $4.40
- Average True Range (ATR)
- TOMZ 0.04
- CING 0.29
- MACD
- TOMZ -0.01
- CING -0.02
- Stochastic Oscillator
- TOMZ 4.43
- CING 0.01
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.